Abstract
Pharmaceutical nanocarriers are increasingly recognized for their potential in overcoming the blood-brain barrier (BBB) to enable targeted drug delivery to the brain. These carriers, including liposomes, polymeric nanoparticles, and solid lipid nanoparticles, have revolutionized the field of brain-targeted drug delivery, offering enhanced bioavailability, controlled release, and reduced side effects. The ability to encapsulate both hydrophobic and hydrophilic drugs in nanocarriers has opened new avenues for treating neurological disorders such as Alzheimer's disease, Parkinson's disease, and brain tumors. This article reviews the mechanisms, advantages, and challenges associated with pharmaceutical nanocarriers in brain drug delivery, focusing on the various approaches being developed to improve the efficiency of these systems.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. James Smith (Author)